ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
4 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: Sigma Theta Tau International/Hill-Rom Environment of Elder Care Nursing Research Grant
The Environment of Elder Care Nursing Research Grant co-sponsored by Hill-Rom will advance the science of nursing through research focused on critical aspects of elder care including clear lungs, no falls, safe skin, patient comfort and ease-of-use. Applications from novice researchers who have received no other national research funds are encouraged. Preference will be given to Sigma Theta Tau International members, other qualifications being equal.
Funds for this grant are provided by Hill-Rom. Allocation of funds is based on the quality of the proposed research, the future promise of the applicant and the applicant's research budget.
Funds for this grant do not cover expenses incurred prior to the funding date.
Registered nurse with a current license.
Hold at minimum a master's degree or its equivalent, and/or be enrolled in a doctoral program.
Submission of completed research application packet and a signed research agreement via our online submission system.
Ready to implement research project when funding is received.
Submit to STTI a final report; submit completed abstract to STTI's Virginia Henderson Global Nursing e-Repository.
Submit an abstract for publication to Hill-Rom regarding the research done as a product of the grant, and credit research grant partners in all publications and presentations of the research.
Grants available: 1 per year
Funding: up to US $9,000
Deadline: 1 July 2014
Funding date: 1 November 2014
Sigma Theta Tau International
Phone: 888.634.7575 (US/Canada) or +1.317.634.8171(International)
How to apply: All applications must be submitted via the online submission system.
Call for Applications: Sigma Theta Tau International/Association of periOperative Registered Nurses Grant
To encourage qualified nurses to conduct research related to perioperative nursing practice and contribute to the development of perioperative nursing science. All relevant research topics will be considered although priority will be given to research studies that relate to the AORN research priorities:
Perioperative nursing care that contributes to quality, cost-effective patient outcomes related to safety, physiological integrity and behavioral responses
Validation, testing and refinement of the Perioperative Nursing Data Set
Perioperative Nursing Leadership/Management
Evidence based practice
Health and safety issues affecting perioperative nurses and patients.
Perioperative nursing leadership/management (i.e. recruitment/retention, resource management, effective teams)
Funds for this grant are provided jointly by the AORN Foundation and Sigma Theta Tau International. Allocation of funds is based on the quality of the research, the future promise of the applicant, and the applicant’s research budget.
Principal investigator is required to be a registered nurse (with a current license) in the perioperative setting or a registered nurse who demonstrates interest in or significant contributions to perioperative nursing practice.
Principal investigator must have, at a minimum, a master’s degree in nursing.
Membership in either organization is acceptable but not required.
Grants available: 1 per year
Funding: $5,000 (max)
Deadline: 1 April 2014
Funding date: 1 July 2014
For an application please contact:
Lisa Spruce, RN, DNP, ACNS, ACNP, ANP, CNOR
Director, Evidence-Based Perioperative Practice
Association of periOperative Registered Nurses (AORN)
2170 S. Parker Road, Suite 400
Denver, CO 80231-571
303.755.6304 ext. 207
800.755.2676 ext. 207
Call for Nominations: C.E. Pippenger Award
Presented for Outstanding Contributions to Therapeutic Drug Monitoring
This award is presented in honor of Dr. C.E. Pippenger, International Association of Therapeutic Drug Monitoring and Clinical Toxicology Honorary Member.
Terms of Reference
The Award shall be presented to an individual as a mark of recognition of outstanding contributions to Therapeutic Drug Monitoring. The recipient must be a member in good standing of the Association at the day of the award presentation.
The Award shall usually be presented bi-annually, but if in the opinion of the Awards Committee no suitable candidate is available, the Award shall not be presented.
The Award shall be accompanied by a framed certificate and an honorarium in the amount of USD $1,500.
The recipient of the Award shall be chosen by the Awards Committee and approved by the IATDMCT Executive no later than four (4) months prior to the Congress at which the Award will be presented. In order to avoid a conflict of interest, the Awards Committee must not communicate with the IATDMCT Executive or Council on their selection prior to making their final decision. However, the final Awards Committee decision requires the approval of the IATDMCT Executive.
Members of IATDMCT may propose suitable candidates to the Awards Committee through the Business Office of the association.
Nominations from the membership must be accompanied by a curriculum vitae including a list of publications, and a letter from the nominator containing an evaluation and appraisal of the nominee for the award. Additional letters of support by members of the Association or other respected scientists are helpful for the Selection Committee.
The presentation of the Award shall normally be at the Opening Ceremonies of the Congress of the association. The recipient of the Award is not usually expected to give an address or present a paper.
Sponsored by Siemens Healthcare Diagnostics
IATDMCT members are invited to nominate individuals for the IATDMCT awards. The award presentations will take place at the Opening Ceremonies of the bi-ennial Internation Congress of the IATDMCT.
How to Nominate: Nominations from members must be accompanied by curriculum vitae including a list of publications and a letter of support from the nominator containing an evaluation and appraisal of the nominee for the award. Additional letters of support from members of the Association or other respected scientists are welcomed as supporting information for the Selection Committee.
Deadline: March 31, 2015
Nominations must be received by March 31 of the Congress year.
Sander Vinks, Chair
Call for Nominations: Victor Armstrong Young Investigator Award
Presented to a Young Investigator for Exceptional Scientific Achievements Early in his/her Career.
This award is presented in honor of Dr. Victor Armstrong, International Association of Therapeutic Drug Monitoring and Clinical Toxicology Member, who passed away February 27, 2010.
Formerly the Young Investigator Award, at the May 27, 2010 meeting of the IATDMCT Executive this award was renamed the Victor Armstrong Young Investigator Award in honor of Dr. Victor Armstrong who passed away February 27, 2010.
The Award recognizes and encourages the professional development and achievements of a young investigator who has demonstrated exceptional scientific achievements early in his/her career.
The recipient must be a member in good standing of the Association on the day of the award presentation.
She/he must be 40 years of age or younger on the date specified as the deadline for receipt of nominations.
The Award shall be accompanied by a framed certificate and an honorarium in the amount of USD 1,000.
The recipient of the Award shall be chosen by the Awards Committee and approved by the IATDMCT Executive no later than four (4) months prior to the Congress at which the Award will be presented. In order to avoid a conflict of interest, the Awards Committee must no communicate with the IATDMCT Executive or Council on their selection prior to making their final decision. However, the final Awards Committee decision requires the approval of the IATDMCT Executive.
Nominations from the membership must be accompanied by a curriculum vitae including a list of publications, and a letter from the nominator containing an evaluation of the originality and importance of the candidate's contributions to therapeutic drug monitoring and/or clinical toxicology. Additional letters of support by members of the Association or other respected scientists are helpful for the Selection Committee.
Sponsored by Lippincott Williams & Wilkins